RSV Infection linked to risk of development of Type 2 Diabetes, suggests study
Findings from a new study indicate a potential association between respiratory syncytial virus (RSV) infection and the later development of type 2 diabetes mellitus (T2DM). However, further prospective studies and mechanistic research are needed to confirm this relationship and clarify the biological pathways involved.
Whether respiratory syncytial virus (RSV) infection contributes to the development of type 2 diabetes (T2DM) or serves as an early warning indicator of type 2 diabetes mellitus risk remains unclear. The study utilized TriNetX US Collaborative Database between January 1, 2022, and March 31, 2024. Patients with a history of type 2 diabetes mellitus diagnosis, antidiabetic medication use, or HbA1c ≥ 6.5 were excluded. Respiratory syncytial virus infection was designated as the index event with propensity score matching. The risk of type 2 diabetes mellitus was assessed using Cox proportional hazards regression models. Sensitivity analyses were conducted for two periods: 2010–2015 and 2016–2019, and across different databases.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.